DIAZEPAM INJECTION USP
TELIGENT OU
This is a national manufacturer shortage report. It does not confirm whether the product is unavailable at your local pharmacy — call ahead or ask your pharmacist.
Quick answers
Is there a shortage of DIAZEPAM INJECTION USP in Canada?
Yes. DIAZEPAM INJECTION USP 5MG has an active shortage reported to Health Canada (last updated May 21, 2020).
Why is DIAZEPAM INJECTION USP not available?
The reason the manufacturer reported: Disruption of the manufacture of the drug.
When will DIAZEPAM INJECTION USP be available again?
No estimated resolution date has been reported yet. Follow this page to get an email as soon as the status changes.
Other Products Containing the Same Active Ingredient
These are other Health Canada-approved human drug products containing the same active ingredient, not currently reported in shortage. Strength, dosage form, and route can still differ — ask your pharmacist whether any of these are appropriate for you. This isn't a guarantee of current stock.
Closest Matches
DIAZEPAM INJECTION USP
SANDOZ CANADA INCORPORATED
Other Products
VIVOL
AXXESS PHARMA INC.
MEVAL 5
MEDIC LABORATORY LTÉE
E PAM TAB 5MG
ICN CANADA LTD.
VALIUM
SEARCHLIGHT PHARMA INC
NOVO-DIPAM TAB 5MG
NOVOPHARM LIMITED
What this means
Does this mean my pharmacy is out of stock?
Not necessarily — a national shortage doesn't mean every pharmacy has run out. Some locations may still have stock, especially of a specific strength or pack size.
What should I do?
Contact your pharmacy before your current supply runs low, and ask your pharmacist about next steps if they're out.
DIN
02385392
Strength
5MG
Dosage Form
SOLUTION
Route
INTRAMUSCULAR INTRAVENOUS
Compare with another product →
Shortage Timeline
Approximate — based on the dates HPSC reports were last updated, not confirmed onset or resolution dates. Gaps between bars are periods with no shortage on file.